길리어드 사이언스, Inc.
US ˙ NasdaqGS ˙ US3755581036

SecurityGILD / Gilead Sciences, Inc.
InstitutionGlg Llc
Latest Disclosed Ownership88,058 shares
Latest Disclosed Value $ 6,308,000
Glg Llc ownership in GILD / Gilead Sciences, Inc.

On February 14, 2018 - Glg Llc filed a 13F-HR form disclosing ownership of 88,058 shares of Gilead Sciences, Inc. (US:GILD) valued at $6,308,475 USD as of December 31, 2017. The entity filed a previous 13F-HR on November 14, 2017 disclosing 63,058 shares of Gilead Sciences, Inc.. This represents a change in shares of 39.65% during the quarter. The current value of the position is $11,375,332 USD.

Glg Llc has a history of taking positions in derivatives of the underlying security (GILD) in the form of stock options. The firm currently holds call options representing 160,100 of underlying shares valued at $11,470,000 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

GILD / Gilead Sciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2018-02-14 2017-12-31 13F GILEAD SCIENCES COM 375558103 88,058 25,000 39.65 6,308 23.47 0.4522
2017-11-14 2017-09-30 13F GILEAD SCIENCES COM 375558103 63,058 -5,862 -8.51 5,109 4.74 0.3315
2017-08-14 2017-06-30 13F GILEAD SCIENCES COM 375558103 68,920 -8,011 -10.41 4,878 -6.64 0.2994
2017-05-15 2017-03-31 13F GILEAD SCIENCES COM 375558103 76,931 -173 -0.22 5,225 -5.36 0.2886
2017-02-14 2016-12-31 13F GILEAD SCIENCES COM 375558103 77,104 4,901 6.79 5,521 -3.36 0.3814
2016-11-14 2016-09-30 13F GILEAD SCIENCES COM 375558103 72,203 -6,955 -8.79 5,713 -13.48 0.4077
2016-08-15 2016-06-30 13F GILEAD SCIENCES COM 375558103 79,158 -29,343 -27.04 6,603 -33.75 0.4967
2016-05-16 2016-03-31 13F GILEAD SCIENCES COM 375558103 108,501 -11,485 -9.57 9,967 -17.91 0.6224
2016-02-16 2015-12-31 13F GILEAD SCIENCES COM 375558103 119,986 -81,456 -40.44 12,141 -38.62 0.7226
2015-11-16 2015-09-30 13F GILEAD SCIENCES COM 375558103 201,442 -5,528 -2.67 19,780 -18.37 0.4946
2015-08-14 2015-06-30 13F GILEAD SCIENCES COM 375558103 206,970 -2,789 -1.33 24,232 17.72 0.5156
2015-05-15 2015-03-31 13F GILEAD SCIENCES COM 375558103 209,759 25,903 14.09 20,584 18.78 0.5865
2015-02-17 2014-12-31 13F GILEAD SCIENCES COM 375558103 183,856 36,235 24.55 17,330 10.28 0.5193
2014-11-14 2014-09-30 13F GILEAD SCIENCES COM 375558103 147,621 -21,890 -12.91 15,714 11.81 0.4179
2014-08-14 2014-06-30 13F GILEAD SCIENCES COM 375558103 169,511 25,190 17.45 14,054 37.42 0.4154
2014-05-15 2014-03-31 13F GILEAD SCIENCES COM 375558103 144,321 144,321 10,227 0.3427
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2018-02-14 2017-12-31 13F GILEAD SCIENCES COM Call 160,100 0.00 11,470 -11.57 n/a n/a n/a
2017-11-14 2017-09-30 13F GILEAD SCIENCES COM Call 160,100 -17.69 12,971 -5.78 n/a n/a n/a
2017-08-14 2017-06-30 13F GILEAD SCIENCES COM Call 194,500 94.50 13,767 102.69 n/a n/a n/a
2017-05-15 2017-03-31 13F GILEAD SCIENCES COM Call 100,000 6,792 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.